Confidential SECOND AMENDED AND RESTATED MASTER SERVICES AGREEMENT PREAMBLEMaster Services Agreement • August 1st, 2012 • Response Genetics Inc • In vitro & in vivo diagnostic substances
This confidential SECOND AMENDED AND RESTATED MASTER SERVICES AGREEMENT (the “Master Agreement”) is dated as of July 26 2012 and made effective as of May 15, 2012 (“Effective Date”) between GLAXOSMITHKLINE BIOLOGICALS S.A. with offices situated at 89 rue de l’Institut, 1330 Rixensart, Belgium, duly registered under the Belgian Company Register with the number RPM Nivelles BE 440.872.918 (“GSK”), and RESPONSE GENETICS INC., a company incorporated in the State of Delaware, whose principal place of business is situated at 1640 Marengo Street, Suite 600, Los Angeles, CA 90033 (“RGI”).
